These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 6201650
1. [High density lipoprotein cholesterol in secondary hyperlipoproteinemias]. Titov VN, Tvorogova MG, Kantardzhian IG, Alamdarova IA, Negovskaia AV. Lab Delo; 1983; (12):11-7. PubMed ID: 6201650 [Abstract] [Full Text] [Related]
4. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia. Oida K, Nakai T, Tamai T, Kutsumi Y, Kobayashi T, Hayashi T, Yamada S, Takeda R. Artery; 1982; 10(4):266-85. PubMed ID: 7181672 [Abstract] [Full Text] [Related]
6. [Correlations of lipoprotein metabolism indicators in persons with low and high cholesterol ester transport activity]. Tvorogova MG, Rozhkova TA, Kukharchuk VV, Titov VN. Vopr Med Khim; 1999; 45(4):332-8. PubMed ID: 10547884 [Abstract] [Full Text] [Related]
10. The peculiarities of lipid and protein components of the high- and low-density lipoproteins in patients suffering from coronary atherosclerosis with different number of affected coronary arteries. Gasilin VS, Kurdanov KhA, Perova NV, Torkhovskaya TI, Polessky VA, Matveeva LS. Cor Vasa; 1981; 23(4):248-56. PubMed ID: 7297073 [Abstract] [Full Text] [Related]
12. [Lecithin-cholesterol acyltransferase activity and lipid composition of high density lipoprotein subfractions in hyperalphalipoproteinemia]. Ozerova IN, Torkhovskaia TI, Polesskiĭ VA, Gerasimova EN. Vopr Med Khim; 1980; 26(3):365-70. PubMed ID: 7456368 [Abstract] [Full Text] [Related]
13. Reduction of low density and high density lipoprotein cholesterol by fat-modified diets. A survey of recent findings. Vessby B, Lithell H, Boberg J. Hum Nutr Clin Nutr; 1982; 36(3):203-11. PubMed ID: 6749766 [Abstract] [Full Text] [Related]
14. [Phospholipid characteristics of the HDLP2 and HDLP3 composition in dysalphalipoproteinemia]. Gerasimova EN, Pham TM, Suchkova SN, Chepurnenko NV, Polesskiĭ VA. Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(2):86-93. PubMed ID: 7053079 [Abstract] [Full Text] [Related]
16. [Lipids, lipoproteins, arterial accidents and oral contraceptives]. Bakir R, Hilliquin P. Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243 [Abstract] [Full Text] [Related]
17. [Apoproteins C and E from very low and high density lipoproteins in men with dysalphalipoproteinemia]. Shcherbakova IA, Gerasimova EN, Perova NV, Chernyshova NP. Vopr Med Khim; 1982 Jan; 28(3):117-23. PubMed ID: 7101813 [Abstract] [Full Text] [Related]
18. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel. Teichmann A. Int J Fertil Menopausal Stud; 1995 Jan; 40 Suppl 2():98-104. PubMed ID: 8574257 [Abstract] [Full Text] [Related]
19. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus. Petersen KR. Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723 [Abstract] [Full Text] [Related]